TGFβ: Protecting PD-1 from mRNA Decay
- PMID: 33262162
- DOI: 10.1158/2326-6066.CIR-20-0881
TGFβ: Protecting PD-1 from mRNA Decay
Abstract
Coordinated regulation of genes is key to determining cell fate. Although this is best understood for master regulator transcription factors, posttranscriptional regulation of mRNA stability and nuclear export can be equally effective at altering gene expression. Indeed, the heterogeneity of RNA-binding proteins and miRNAs suggests a deep complexity to posttranscriptional regulatory processes. In this issue, Wu and colleagues report a new mechanism for TGFβ-mediated immune suppression via regulation of mRNA-binding proteins in CD8+ T cells.See article by Wu et al., p. 1470.
©2020 American Association for Cancer Research.
Comment on
-
Tumor Cell-Derived TGFβ1 Attenuates Antitumor Immune Activity of T Cells via Regulation of PD-1 mRNA.Cancer Immunol Res. 2020 Dec;8(12):1470-1484. doi: 10.1158/2326-6066.CIR-20-0113. Epub 2020 Sep 30. Cancer Immunol Res. 2020. PMID: 32999004
References
-
- Batlle E, Massagué J. Transforming growth factor-β signaling in immunity and cancer. Immunity. 2019;50:924–40.
-
- Dougan M, Dranoff G, Dougan SK. Cancer immunotherapy: beyond checkpoint blockade. Annu Rev Cancer Biol. 2019;3:55–75.
-
- Tian B, Manley JL. Alternative polyadenylation of mRNA precursors. Nat Rev Mol Cell Biol. 2017;18:18–30.
-
- Wu P, Geng B, Chen Q, Zhao E, Liu J, Sun C, et al. Tumor cell-derived TGFβ1 attenuates antitumor immune activity of T cells via regulation of PD-1 mRNA. Cancer Immunol Res. 2020;8:1470–84.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials